Sen. Jack Reed.
Senator John "Jack" Reed announced Tuesday that he sold
Stocks and stocks of some other reputed tech names in late February.
The Rhode Island Democrat, who has several committees including Appropriations, Armed Services, Banking, Housing and Urban Affairs, has sold Apple shares (ticker: AAPL) and shares of
(QCOM). Reed also sold shares in medical device companies
(SYK). The published sales were all made on February 28, according to a registration form submitted by Reed.
The Senate Bureau of Reed did not respond immediately to a request for comment on the sales.
Reed sold Apple shares worth $ 15,001 to $ 50,000 held in a personal account and another $ 1,001 to 15,000 shares of the iPhone maker from a common account. The information given by the supervisory authorities does not require specific amounts but only areas.
Apple stock had a difficult time when 2018 ended; The stock ended the year with a 6.8% decline in news. The iPhone demand weakened. When 2019 got underway, Apple interrupted the forecast and found that the economy slowed down, which had a negative impact in China. But over time, the stock has gained a foothold. With Wednesday's first day of spring arriving, Apple's share price has risen 18% since the beginning of the year since the beginning of the year. That's even better than that
S & P 500s
Increase by 13% in 2019. The Apple stock is a Barrons from Barron for 2019, and we believe the company could package its services or iPhones and services into attractive monthly subscriptions.
The Xilinx share is trading in One crack in 2019. The chip manufacturer's stock brands have so far risen by 49% in 2019, relying on a gain of 26% in 2018. We found that a Bank of America analyst Merrill Lynch believes Xilinx is the best in its class in terms of sales and earnings per share. As with Apple, Reed sold Xilinx shares of $ 15,001 to $ 50,000 from a private account and from $ 1,001 to $ 15,000 in a common account.
Reed also sold $ 15,001 to $ 50,000 in Qualcomm stock, which had remained unchanged in 2019. For 2018, a loss of 11% was recorded after the company abandoned a buy attempt
(NXPI) in the middle of the year and later issued grim guidelines. Earlier this month, the chip maker claimed that US national security could be undermined by a case of the Federal Trade Commission, which charges Qualcomm's fees for the patent royalty for smartphones.
Reed sold Stryker shares from his private account of $ 15,001 to $ 50,000 and a common account of $ 1,001 to $ 15,000. The Stryker share has so far risen by 25% in 2019 after a flat year in 2018. We found that the company's sales and profits continued to increase during the global economic downturn a decade ago. The manufacturer of replacement hips and knees also enjoys a high level of customer loyalty.
The sale of shares of Apple, Xilinx, Qualcomm and Stryker continues a pattern reed set from early this year. His only other 2019 transaction disclosure filed on March 1 included sales of each of these four shares from $ 1,001 to $ 15,000 from his joint account.